341 related articles for article (PubMed ID: 23808938)
1. Aberrant cytokeratin expression as a possible prognostic predictor in poorly differentiated colorectal carcinoma.
Yamagishi H; Imai Y; Okamura T; Fukuda K; Ono Y; Ban S; Inoue T; Ueda Y
J Gastroenterol Hepatol; 2013 Dec; 28(12):1815-22. PubMed ID: 23808938
[TBL] [Abstract][Full Text] [Related]
2. Differential mucin phenotypes and their significance in a variation of colorectal carcinoma.
Imai Y; Yamagishi H; Fukuda K; Ono Y; Inoue T; Ueda Y
World J Gastroenterol; 2013 Jul; 19(25):3957-68. PubMed ID: 23840140
[TBL] [Abstract][Full Text] [Related]
3. Expression of cytokeratin 20 indicates invasive histological phenotype in poorly differentiated colorectal adenocarcinoma.
Imai Y; Yamagishi H; Fukuda K; Okamura T; Ono Y; Ban S; Inoue T; Ueda Y
Anticancer Res; 2014 Jan; 34(1):159-67. PubMed ID: 24403457
[TBL] [Abstract][Full Text] [Related]
4. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: I. Cytokeratin profile in 42 cases.
Terada T
Int J Clin Exp Pathol; 2013; 6(4):703-10. PubMed ID: 23573317
[TBL] [Abstract][Full Text] [Related]
5. CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma.
Shin JH; Bae JH; Lee A; Jung CK; Yim HW; Park JS; Lee KY
Jpn J Clin Oncol; 2010 Mar; 40(3):208-13. PubMed ID: 19926591
[TBL] [Abstract][Full Text] [Related]
6. Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary.
Vang R; Gown AM; Zhao C; Barry TS; Isacson C; Richardson MS; Ronnett BM
Am J Surg Pathol; 2007 Jun; 31(6):854-69. PubMed ID: 17527072
[TBL] [Abstract][Full Text] [Related]
7. Cytokeratin 7 and cytokeratin 20 expression in colorectal adenocarcinomas.
Bayrak R; Yenidünya S; Haltas H
Pathol Res Pract; 2011 Mar; 207(3):156-60. PubMed ID: 21282015
[TBL] [Abstract][Full Text] [Related]
8. Cytokeratin 7 and 20 expression in gallbladder carcinoma.
Kalekou H; Miliaras D
Pol J Pathol; 2011; 62(1):25-30. PubMed ID: 21574103
[TBL] [Abstract][Full Text] [Related]
9. Tubular carcinoids of the appendix: the CK7/CK20 immunophenotype can be a diagnostic pitfall.
Matsukuma KE; Montgomery EA
J Clin Pathol; 2012 Jul; 65(7):666-8. PubMed ID: 22461652
[TBL] [Abstract][Full Text] [Related]
10. Identification of relevant prognostic values of cytokeratin 20 and cytokeratin 7 expressions in lung cancer.
Luo HT; Liang CX; Luo RC; Gu WG
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28827446
[TBL] [Abstract][Full Text] [Related]
11. Cytokeratin expression profiling in gastric carcinoma: clinicopathologic significance and comparison with tumor-associated molecules.
Takami H; Sentani K; Matsuda M; Oue N; Sakamoto N; Yasui W
Pathobiology; 2012; 79(3):154-61. PubMed ID: 22286119
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical staining of cytokeratin 20 and cytokeratin 7 in colorectal carcinomas: Four different immunostaining profiles.
Al-Maghrabi J; Emam E; Gomaa W
Saudi J Gastroenterol; 2018; 24(2):129-134. PubMed ID: 29637921
[TBL] [Abstract][Full Text] [Related]
13. Differential diagnostic and functional role of the multi-marker phenotype CDX2/CK20/CK7 in colorectal cancer stratified by mismatch repair status.
Lugli A; Tzankov A; Zlobec I; Terracciano LM
Mod Pathol; 2008 Nov; 21(11):1403-12. PubMed ID: 18587323
[TBL] [Abstract][Full Text] [Related]
14. CK20 and CK7 protein expression in colorectal cancer: demonstration of the utility of a population-based tissue microarray.
Hernandez BY; Frierson HF; Moskaluk CA; Li YJ; Clegg L; Cote TR; McCusker ME; Hankey BF; Edwards BK; Goodman MT
Hum Pathol; 2005 Mar; 36(3):275-81. PubMed ID: 15791572
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathologic characteristics and histogenesis of mucinous tumor of peritoneum].
Zhang H; Sun Y; Huang X; Jia L; Bai Y; Cao D
Zhonghua Bing Li Xue Za Zhi; 2014 Mar; 43(3):163-8. PubMed ID: 24842014
[TBL] [Abstract][Full Text] [Related]
16. Cytokeratin 7 expression as a predictor of an unfavorable prognosis in colorectal carcinoma.
Hrudka J; Fišerová H; Jelínková K; Matěj R; Waldauf P
Sci Rep; 2021 Sep; 11(1):17863. PubMed ID: 34504224
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic value of SATB2, CK7 and CK20 in colorectal cancer].
Lyn J; Wang Y; Wang F; Shen M; Zhou X
Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):578-81. PubMed ID: 26705182
[TBL] [Abstract][Full Text] [Related]
18. Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary.
Park SY; Kim HS; Hong EK; Kim WH
Hum Pathol; 2002 Nov; 33(11):1078-85. PubMed ID: 12454811
[TBL] [Abstract][Full Text] [Related]
19. BRAF-mutated microsatellite stable colorectal carcinoma: an aggressive adenocarcinoma with reduced CDX2 and increased cytokeratin 7 immunohistochemical expression.
Landau MS; Kuan SF; Chiosea S; Pai RK
Hum Pathol; 2014 Aug; 45(8):1704-12. PubMed ID: 24908142
[TBL] [Abstract][Full Text] [Related]
20. Aberrant pattern of the cytokeratin 7/cytokeratin 20 immunophenotype in colorectal adenocarcinomas with BRAF mutations.
Gurzu S; Jung I
Pathol Res Pract; 2012 Mar; 208(3):163-6. PubMed ID: 22361037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]